{"DataElement":{"publicId":"6161704","version":"1","preferredName":"Non-Index Lesion irRC Non-Measurable Overall Response Category","preferredDefinition":"Text term to represent the overall disease response in tumor lesions other than the largest tumor lesion targeted by therapy using the  Immune-Related Response Criteria (irRC) criteria.","longName":"NON_IDX_irRC_OVR_RESP_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6160010","version":"1","preferredName":"Non-Index Lesion Response","preferredDefinition":"Any tumor lesion other than the largest tumor lesion targeted by therapy._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","longName":"4472275v1.0:2193203v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"4472275","version":"1","preferredName":"Non-Index Lesion","preferredDefinition":"Any tumor lesion other than the largest tumor lesion targeted by therapy.","longName":"C110962","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Index Lesion","conceptCode":"C110962","definition":"Any tumor lesion other than the largest tumor lesion targeted by therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"01B516DB-222B-FA0F-E050-BB89AD4354CC","latestVersionIndicator":"Yes","beginDate":"2014-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-08-28","modifiedBy":"ONEDATA","dateModified":"2014-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2193203","version":"1","preferredName":"Response","preferredDefinition":"Response is any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","longName":"C25755","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EACFDBFA-EFCE-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRC: Immune-Related Response Criteria-2009","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"68E1E0E5-A936-33BB-E053-F662850A5F14","latestVersionIndicator":"Yes","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-02","modifiedBy":"HARTLEYG","dateModified":"2018-04-05","changeDescription":"4/2/18 jk created for DCI study and iRECIST FG activity.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6161699","version":"1","preferredName":"irRC Non-Measurable Overall Response Category","preferredDefinition":"A set of response criteria designed to capture additional response patterns observed with immune therapy beyond those described by Response Evaluation Criteria in Solid Tumors (RECIST) or WHO criteria._Not possible to be measured._An assessment of the overall response of the disease to the therapy._A grouping of items based on some commonality or by user defined characteristics.","longName":"6161699v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"6","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Absent","valueDescription":"Absent","ValueMeaning":{"publicId":"2562943","version":"1","preferredName":"Absent","longName":"2562943","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C2EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"REEVESD","dateModified":"2014-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F9BBE-0F3E-3791-E053-F662850A20CB","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"Stable","valueDescription":"Stable","ValueMeaning":{"publicId":"2570725","version":"1","preferredName":"Stable","longName":"2570725","preferredDefinition":"Stable; subject to little fluctuation; showing little if any change.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable","conceptCode":"C30103","definition":"Subject to little fluctuation; showing little if any change.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E152-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"REEVESD","dateModified":"2011-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F9BBE-0F48-3791-E053-F662850A20CB","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"Unequivocal progression","valueDescription":"Unequivocal Progression","ValueMeaning":{"publicId":"4379652","version":"1","preferredName":"Unequivocal Progression","longName":"4379652","preferredDefinition":"An overall level of substantial worsening in non-target disease that is of a magnitude that, even in the presence of SD or PR in target disease, the treating physician would feel it important to change therapy. (RECIST)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unequivocal Progression","conceptCode":"C96644","definition":"An overall level of substantial worsening in non-target disease that is of a magnitude that, even in the presence of SD or PR in target disease, the treating physician would feel it important to change therapy. (RECIST)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD39AC65-D202-89E1-E040-BB89AD430453","latestVersionIndicator":"Yes","beginDate":"2014-07-02","endDate":null,"createdBy":"SCOTTM","dateCreated":"2014-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F9BBE-0F52-3791-E053-F662850A20CB","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6161698","version":"1","preferredName":"Immune-Related Response Criteria Non-Measurable Overall Response Category","preferredDefinition":"A set of response criteria designed to capture additional response patterns observed with immune therapy beyond those described by Response Evaluation Criteria in Solid Tumors (RECIST) or WHO criteria.:Not possible to be measured.:An assessment of the overall response of the disease to the therapy.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C148192:C25589:C96613:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria","conceptCode":"C148192","definition":"A set of response criteria designed to capture additional response patterns observed with immune therapy beyond those described by Response Evaluation Criteria in Solid Tumors (RECIST) or WHO criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Non-Measurable","conceptCode":"C25589","definition":"Not possible to be measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Overall Response","conceptCode":"C96613","definition":"An assessment of the overall response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F9BBE-0F14-3791-E053-F662850A20CB","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRC: Immune-Related Response Criteria-2009","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"691F9BBE-0F25-3791-E053-F662850A20CB","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"KNABLEJ","dateModified":"2018-10-23","changeDescription":"10/23/18 jk chg reg status to Standard for RECIST defined PV list; do not add PVs without checking latest version of guideline.  4/5/18 jk created for DCI study and immune RECIST FG activities.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6160006","version":"1","longName":"irRC","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Non-index lesion irRC overall","type":"Preferred Question Text","description":"Non-index lesion irRC overall response","url":null,"context":"NCI Standards"},{"name":"irRC instruction","type":"Alternate Question Text","description":"CDE captures the overall response of all Non-index lesions response.  Use CDE 6160136 to collect  individual Non-index lesion responses (log line).","url":null,"context":"NCI Standards"},{"name":"irRC","type":"Alternate Question Text","description":"Non-index lesion overall response","url":null,"context":"NCI Standards"}],"origin":"irRC: Immune-Related Response Criteria-2009","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"691FE31B-B45B-5739-E053-F662850A27D2","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-10-22","changeDescription":"10-22-18 Registration status changed to Standard/TMT. 4/5/18 jk created for DCI study and immune RECIST FG activities.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}